ASCO Daily News

American Society of Clinical Oncology (ASCO)

Immunotherapy

Breast Cancer

Lung Cancer

ASCO Annual Meeting

Artificial Intelligence

Clinical Trials

Oncology

Colorectal Cancer

Multiple Myeloma

Prostate Cancer

Cancer Care

Chemotherapy

Neoadjuvant Therapy

Acute Myeloid Leukemia

Melanoma

Circulating Tumor DNA

Non-Small Cell Lung Cancer

Pembrolizumab

Gastrointestinal Cancers

Ovarian Cancer

The ASCO Daily News Podcast features oncologists discussing the latest research and therapies in their areas of expertise.

135 ratings

Publishes	Weekly	Episodes	277	Founded	11 years ago
Number of Listeners		Categories	MedicineHealth & Fitness

Listen to this Podcast

Guests Host Reviews Charts Talking Points

Latest Episodes

ASCENT and DESTINY-Breast09 Trials: Applying Frontline Data in Metastatic Breast Cancer Care

Dr. Sara Tolaney joins Dr. Monty Pal to discuss optimizing the sequencing and combination of antibody-drug conjugates for metastatic HER2-positive and triple-negative breast cancer, as well as guidelines for managing serious toxicities like ILD and n... more

15 Oct 2026 • 20 min • Most popular

CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management

Myeloma specialists Dr. Marc Braunstein and Dr. Rahul Banerjee join Dr. Monty Pal to discuss recent breakthroughs for patients with multiple myeloma, including expert advice on how to manage side effects and identify the right treatment among a serie... more

1 Oct 2026 • 21 min

Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok

Dr. Jedd Wolchok, a pioneer in melanoma research, joins Dr. Monty Pal to break down practice-changing advances in the field, including landmark 10-year CheckMate-067 survival data, safer immunotherapy dosing, and the rise of neoadjuvant treatment.

... more

10 Sep 2026 • 20 min

Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities

Dr. Monty Pal and Dr. Petros Grivas discuss the rapidly evolving management of bladder cancer, including key updates in non-muscle-invasive disease, the integration of novel therapies in the advanced setting, and practical strategies for managing tox... more

3 Sep 2026 • 23 min

Key Facts

Accepts Guests

Accepts Sponsors

Contact Information

Podcast Host

Number of Listeners

Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc DocsSam and Karine

Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)

ASCO EducationAmerican Society of Clinical Oncology (ASCO)

ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)

JAMA Clinical ReviewsJAMA Network

Recent Guests

Marc Braunstein

Associate Professor of Medicine at NYU; practices in Mineola at NYU Grossman Long Island School of Medicine

New York University (NYU)

Episode: CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management

Rahul Banerjee

Associate Professor at the Fred Hutch; focuses on talks management and patient experience in myeloma

Fred Hutchinson Cancer Research Center

Episode: CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management

Jedd Wolchok

Meyer Director of the Sandra and Edward Meyer Cancer Center at the Weill Cornell Medicine; attending oncologist

Weill Cornell Medicine, NewYork-Presbyterian

Episode: Are We Curing Advanced Melanoma? A Conversation With Dr. Jedd Wolchok

Petros Grivas

Professor of Medicine, University of Washington; Medical Director of the International Program and Local/Regional Outreach; Clinical Research Division at Fred Hutch

University of Washington; Fred Hutchinson Cancer Center

Episode: Updates in Bladder Cancer: From Intravesical Breakthroughs to Managing Toxicities

Regina Barragán-Carrillo

Geomedical Oncologist and Clinical Researcher at Mexico's National Cancer Institute

National Cancer Institute, Mexico

Episode: How Do We Translate ASCO26 Research Into Practice in Latin America?

Rachna Shroff

Chief of the division of Hematology and Oncology, University of Arizona College of Medicine, Tucson; Professor of Medicine; endowed professor of GI oncology

University of Arizona College of Medicine

Episode: GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?

Atul Batra

Professor of Medical Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi

AIIMS New Delhi

Episode: From Abstract to Action: Translating ASCO26 Research Into Global Practice

Roselle De Guzman

Chair-elect of the 2026 ASCO Breakthrough Program Committee; Associate professor and medical oncologist

Manila Central University, FTT Medical Foundation Hospital; ASCO Asia-Pacific Regional Council former chair

Episode: Liquid Biopsy, AI, and Other Global Innovations From 2026 ASCO Breakthrough

Hope Rugo

Director of the Women's Cancer Program and Division Chief of Breast Medical Oncology at City of Hope Cancer Center

City of Hope

Episode: Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1

Host

Monty Pal

Primary host of the show, physician-scientist with affiliations at City of Hope (Los Angeles) and related ASCO Daily News leadership.

Reviews

4.7 out of 5 stars from 135 ratings

Accessible high yield content
As a medical resident, I’m impressed by how this podcast is able to offer expert-driven insights into the cutting edge of oncology without losing listeners in the weeds of a highly specialized topic. These episodes are concise, charismatically delivered, and fascinating.
Apple Podcasts
5
Leigh_k_k
United States9 months ago
No help to practice. Agenda driven.
None of this helps me in my practice. It seems like an agenda driven outlet with very little, if any practice changing information.
Apple Podcasts
1
D0ct0r.J
United States4 years ago
Advanced prostrate cancer
Exceptional research done by these doctors and researchers- someone in my family has advanced prostrate cancer - which has moved into hip bone.
It is so scary .
Right now he’s on hormone therapy . To reduce the size of the gland.
He’s 84 and is in excellent health.
He’s in Carmel so if there are trials or anything else I’d love to pass the information on to him.
After listening to this podcast I am excited about the novel studies /trials on the horizon .
The fact that many cancer patie... more
Apple Podcasts
5
dinar320
United States4 years ago
Ask for the draft of the program
Would you please give us the draft of this program！Thanks a lot！
Apple Podcasts
5
猫小猫2009
China6 years ago
Dr.James Gulley
Thank you for this informative and reassuring podcast. The interviewer allowed Dr. Gulley lots of time to share his knowledge and asked only relevant questions. More like this please.
Apple Podcasts
5
JJGeneva
United Kingdom7 years ago

Embed These Reviews on a Website

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Strong appreciation for accessible explanations of complex trials and data.

Concise, high-yield oncology content with expert-driven insights.

Guest mentions like Dr. Gulley are praised for relevant questions and depth.

Host changes are well-received and improve the intimate understanding of cancer topics.

Listener notes call for more practical guidance; some feel content is agenda-driven.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts	#249	United States/Health & Fitness/Medicine
Apple Podcasts	#185	Australia/Health & Fitness/Medicine
Apple Podcasts	#209	France/Health & Fitness/Medicine
Apple Podcasts	#249	Italy/Health & Fitness/Medicine
Apple Podcasts	#11	China/Health & Fitness/Medicine
Apple Podcasts	#38	Japan/Health & Fitness/Medicine

Talking Points

Recent interactions between the hosts and their guests.

CAR T Cells and Bispecific Antibodies: Navigating the New Era in Multiple Myeloma Management

Q: How does the new era of therapies represent a sea change from the triple regimens used previously in multiple myeloma?

The shift is towards using CAR T and bispecifics earlier in the disease course, which not only improves functional status and disease control but also opens the possibility of longer remissions and potential cures in a subset of patients.

How Do We Translate ASCO26 Research Into Practice in Latin America?

Q: How many patients actually present early enough to benefit from this type of therapy in our settings?

Regina explains that while PSA screening and early diagnosis are important, the real challenge is creating pathways that ensure timely diagnosis, referral, high-quality imaging, and access to multidisciplinary care so that patients who could benefit are identified and treated earlier.

GLP-1 Receptor Agonists in GI Cancers: Hype or Promise?

Q: Do GLP-1s work differently across cancer types?

The data suggest variability by tumor type, with clearer signals in certain GI cancers and liver-related contexts, while benefits in prostate or renal cell cancers are less clear, underscoring the need for prospective and subtype-specific studies.

From Abstract to Action: Translating ASCO26 Research Into Global Practice

Q: How is the Proteus data likely to change practice in India compared with the US?

Atul explains that while the proteus approach offers a new option, decisions will still be driven by local cost, access, and multidisciplinary team considerations, with some patients preferring or needing radiation-based pathways depending on circumstances.

Breast Cancer Highlights From ASCO26: OPTIMA, lidERA, and VIKTORIA-1

Q: How should clinicians apply the Optima test-directed approach in early-stage breast cancer?

In postmenopausal patients with one to three positive nodes, Optima suggests many may avoid chemotherapy when a low risk score is used, while premenopausal patients require careful interpretation; Prosigna, not Oncotype, should guide chemotherapy decisions in this context, with longer follow-up needed for broader adoption.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About ASCO Daily News

What is ASCO Daily News about and what kind of topics does it cover?

A clinically focused podcast landscape with a heavy emphasis on cutting-edge oncology research, trial results, and practical implications for patient care. Episodes consistently analyze ASCO findings across GI, GU, breast, and hematologic cancers, often pairing conference data with expert interpretation to translate evidence into clinical decision-making. A notable strength is the breadth of topics—from novel targeted therapies and cellular treatments to real-world access and sequencing considerations—delivered by practicing oncologists and researchers who frequently contextualize data for diverse healthcare settings. The show is particularly valuable for clinicians, researchers, and industry professionals seeking concise, expert-driven ins... more

Where can I find podcast stats for ASCO Daily News?

Rephonic provides a wide range of podcast stats for ASCO Daily News. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to ASCO Daily News and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does ASCO Daily News get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for ASCO Daily News, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for ASCO Daily News?

Rephonic provides comprehensive predictive audience data for ASCO Daily News, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does ASCO Daily News have?

To see how many followers or subscribers ASCO Daily News has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to ASCO Daily News?

These podcasts share a similar audience with ASCO Daily News:

1. Two Onc Docs
2. Journal of Clinical Oncology (JCO) Podcast
3. ASCO Education
4. ASCO Guidelines
5. JAMA Clinical Reviews

How many episodes of ASCO Daily News are there?

ASCO Daily News launched 11 years ago and published 277 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact ASCO Daily News?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for ASCO Daily News?

Rephonic pulls ratings and reviews for ASCO Daily News from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for ASCO Daily News?

Rephonic provides full transcripts for episodes of ASCO Daily News. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on ASCO Daily News?

Recent guests on ASCO Daily News include:

1. Marc Braunstein
2. Rahul Banerjee
3. Jedd Wolchok
4. Petros Grivas
5. Regina Barragán-Carrillo
6. Rachna Shroff
7. Atul Batra
8. Roselle De Guzman

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.

Try it free for 7 days